Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
American Public Education
APEI
$826M
| $8.55M | 0.01% |
885,911
-46,531
| -5% | -$296K |
|
1027
Sempra
SRE
$56.5B
| $8.55M | 0.01% |
114,400
+51,695
| +82% | +$3.7M |
|
|
EVRI
1028
DELISTED
Everi Holdings
EVRI
| $8.54M | 0.01% |
757,600
-129,500
| -15% | -$1.46M |
|
1029
Vishay Intertechnology
VSH
$5.11B
| $8.5M | 0.01% |
354,725
-236,200
| -40% | -$5.48M |
|
1030
AMERISAFE
AMSF
$504M
| $8.49M | 0.01% |
181,600
-7,201
| -4% | -$359K |
|
1031
Blue Bird Corp
BLBD
$2.04B
| $8.49M | 0.01% |
314,922
+99,504
| +46% | +$2.05M |
|
1032
Garrett Motion
GTX
$5.35B
| $8.49M | 0.01% |
877,520
+279,220
| +47% | +$2.15M |
|
1033
Genco Shipping & Trading
GNK
$1.13B
| $8.48M | 0.01% |
511,000
+57,200
| +13% | +$831K |
|
|
HAPN
1034
Happen Inc
HAPN
$2.27B
| $8.44M | 0.01% |
965,733
-637,474
| -40% | -$4.01M |
|
1035
Adient
ADNT
$1.44B
| $8.41M | 0.01% |
231,300
+62,600
| +37% | +$2.15M |
|
1036
Progyny
PGNY
$1.99B
| $8.38M | 0.01% |
225,300
+28,900
| +15% | +$970K |
|
|
PETQ
1037
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $8.37M | 0.01% |
423,784
+108,540
| +34% | +$2.08M |
|
1038
Harmony Biosciences
HRMY
$2.24B
| $8.35M | 0.01% |
258,500
-33,600
| -12% | -$938K |
|
1039
AbCellera Biologics
ABCL
$3.36B
| $8.33M | 0.01% |
1,459,503
-232,550
| -14% | -$1.08M |
|
1040
Ternium
TX
$10.8B
| $8.31M | 0.01% |
195,700
+28,400
| +17% | +$1.1M |
|
1041
Gates Industrial Corporation Ltd.
GTES
$7.05B
| $8.29M | 0.01% |
617,700
+174,300
| +39% | +$2.06M |
|
1042
Allstate
ALL
$64.7B
| $8.24M | 0.01% |
58,900
-185,800
| -76% | -$24.2M |
|
1043
Accel Entertainment
ACEL
$1B
| $8.17M | 0.01% |
795,305
+329,900
| +71% | +$3.4M |
|
1044
AeroVironment
AVAV
$9.59B
| $8.13M | 0.01% |
64,536
+35,600
| +123% | +$4.35M |
|
1045
Crawford & Co Class A
CRD.A
$627M
| $8.13M | 0.01% |
616,755
+8,211
| +1% | +$85.7K |
|
1046
Accuray
ARAY
$32.9M
| $8.11M | 0.01% |
2,865,884
-56,300
| -2% | -$154K |
|
1047
Douglas Emmett
DEI
$1.99B
| $8.07M | 0.01% |
556,700
-125,800
| -18% | -$1.6M |
|
1048
Intapp
INTA
$3.05B
| $8.06M | 0.01% |
212,100
-63,400
| -23% | -$2.33M |
|
1049
NMI Holdings
NMIH
$3.38B
| $8.06M | 0.01% |
271,553
+80,253
| +42% | +$2.24M |
|
1050
Axalta
AXTA
$7.93B
| $8.06M | 0.01% |
237,200
-57,726
| -20% | -$1.73M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.